These findings indicate that SIRT1 may function as a tumor suppressor in the tumorigenesis of different cancers, and SIRT1 activators constitute potential therapeutic tools that may be considered for cancer treatment in the future. This evidence concerns the gene SIRT1 and neoplasm.